TEVA Logo

Teva Pharmaceutical Industries Limited (TEVA) 

NYSE
Market Cap
$19.79B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
739 of 776
Rank in Industry
45 of 47

Largest Insider Buys in Sector

TEVA Stock Price History Chart

TEVA Stock Performance

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it …

Insider Activity of Teva Pharmaceutical Industries Limited

Over the last 12 months, insiders at Teva Pharmaceutical Industries Limited have bought $0 and sold $20.7M worth of Teva Pharmaceutical Industries Limited stock.

On average, over the past 5 years, insiders at Teva Pharmaceutical Industries Limited have bought $0 and sold $10.71M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 209,000 shares for transaction amount of $2.01M was made by BARER SOL J (director) on 2019‑06‑04.

List of Insider Buy and Sell Transactions, Teva Pharmaceutical Industries Limited

2024-08-12SaleExec. VP, European Commercial
98,943
0.0088%
$17.30$1.71M+5.65%
2024-08-09SaleEVP, Business Development
4,065
0.0004%
$17.28$70,243+3.38%
2024-08-09SaleSee "Remarks"
45,060
0.004%
$17.38$782,972+3.38%
2024-08-01SaleSee "Remarks"
24,537
0.0021%
$17.25$423,280+2.39%
2024-06-18Saledirector
519,000
0.045%
$17.03$8.84M+4.17%
2024-05-16SaleChief Accounting Officer
12,635
0.0011%
$16.65$210,377+6.75%
2024-05-15SaleChief Accounting Officer
15,500
0.0014%
$16.80$260,417+3.64%
2024-05-13SaleSee "Remarks"
15,219
0.0013%
$16.74$254,807+2.84%
2024-03-06SaleEVP, Chief Financial Officer
77,550
0.0069%
$13.52$1.05M+24.54%
2024-03-05SaleEVP, International Markets
100,000
0.0089%
$13.52$1.35M+24.43%
2024-03-05SaleExec. VP, European Commercial
48,629
0.0043%
$13.52$657,240+24.43%
2024-03-05SaleSee "Remarks"
1,427
0.0001%
$13.52$19,286+24.43%
2024-03-04SalePresident and CEO
31,061
0.0028%
$13.34$414,270+25.15%
2024-03-04SaleExec. VP, European Commercial
33,512
0.003%
$13.34$446,960+25.15%
2024-03-04SaleSee "Remarks"
8,045
0.0007%
$13.34$107,299+25.15%
2024-03-04SaleSee "Remarks"
3,532
0.0003%
$13.37$47,235+25.15%
2024-02-28SaleExec. VP, European Commercial
20,599
0.0018%
$13.12$270,176+28.42%
2024-02-28SaleExecutive VP Global Operations
9,815
0.0009%
$13.12$128,734+28.42%
2024-02-28SaleSee "Remarks"
1,366
0.0001%
$13.12$17,916+28.42%
2024-02-16SaleExecutive VP Global Operations
173,261
0.0155%
$13.05$2.26M+28.88%

Insider Historical Profitability

<0.0001%
MIGNONE ROBERTOdirector
981000
0.0866%
$17.4721+9.88%
BARER SOL Jdirector
220442
0.0195%
$17.4720+0.5%
Dethlefs SvenEVP, North America Commercial
165381
0.0146%
$17.47117<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$616.67M3.8643.7M+4.89%+$28.78M0.01
ION Asset Management$544.34M3.4138.58M-4.34%-$24.68M39.63
Phoenix Holdings Ltd$488.08M3.0534.58M+0.58%+$2.8M6.78
Migdal Insurance Financial Holdings Ltd$421.29M2.6429.86M+3.24%+$13.24M6.89
Clal Insurance Enterprises Holdings Ltd$406.06M2.5428.79M-12.22%-$56.55M4.71
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.